MedPath
NMPA Approval

Nalmefene Hydrochloride Injection

国药准字H20080652

July 4, 2023

Drug Information

盐酸纳美芬注射液

抒纳

抒纳

注射剂

1ml:0.1mg(以纳美芬计)

化学药品

July 4, 2023

Company Information

Applicant Company

兴城市曹庄工业园区

Manufacturing Company

辽宁省兴城市曹庄工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸纳美芬注射液 - NMPA 批准文号 | MedPath